3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
2
Recruiting
2
Active not recruiting
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
26
Melanoma
25
Stomach Neoplasms
9
Neoplasms
8
Carcinoma, Renal Cell
7
Carcinoma, Hepatocellular
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Hodgkin Disease
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Uveal Melanoma
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Recurrence
2
Mesothelioma, Malignant
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Carcinoma
2
Brain Neoplasms
2
Interventions
Carboplatin
15
Paclitaxel
13
Hyperthermic Intraperitoneal Chemotherapy
6
Cisplatin
5
olaparib
4
niraparib
4
Bevacizumab
4
oregovomab
3
Topotecan
3
Immunohistochemistry
3
Gemcitabine
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Amplified Fragment Length Polymorphism Analysis
3
pembrolizumab
2
liposomal doxorubicin
2
anlotinib
2
ST 1481
2
Radiotherapy
2
Polymerase Chain Reaction
2
Oxaliplatin
2
Neoadjuvant Therapy
2
Gene Expression Profiling
2
Fluorouracil
2
Flow Cytometry
2
Diathermy
2
Cytoreduction Surgical Procedures
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Ovarian Epithelial
×
Nivolumab
×
Clear all
NCT04620954
2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2
Unknown
31 enrolled